A

Alkermes plc
D

ALKS

29.480
USD
-0.27
(-0.91%)
مغلق
حجم التداول
26,522
الربح لكل سهم
1
العائد الربحي
-
P/E
13
حجم السوق
4,769,937,936
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    AAL
    0.000
    (0.00%)
    18.280 USD
    A
    ALGT
    0.590
    (0.58%)
    102.970 USD
    A
    ALK
    -1.095
    (-1.62%)
    66.345 USD
    DAL
    DAL
    -0.380
    (-0.57%)
    65.800 USD
    H
    HA
    0.690
    (3.99%)
    18.000 USD
    J
    JBLU
    0.02500
    (0.33%)
    7.63000 USD
    L
    LUV
    -0.070
    (-0.22%)
    32.100 USD
    S
    SAVE
    -0.24000
    (-18.18%)
    1.08000 USD
    U
    UAL
    1.300
    (1.23%)
    107.400 USD
    المزيد
الأخبار
المقالات

العنوان: Alkermes plc

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.